reNEW entered partnership with EuroGCT
reNEW entered partnership with the newly EU-funded project EuroGCT that will develop an online hub to provide accurate information on the use of cells and genetic material to treat diseases.
The EuroGCT €2m funded initiative will develop an online hub to provide accurate information on the use of cells and genetic material to treat disease, along with evidence-based information to counter misinformation surrounding the therapies.
Gene and cell therapies have the potential to treat many debilitating diseases and conditions. However, more work is needed before safe and effective treatments can be made widely available, experts say.
The project – EuroGCT: The European Consortium for Communicating Gene and Cell Therapy – is led by the University’s School of Biological Sciences and brings together 47 partner organisations and institutions from across Europe, including the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW.
The five-year project will coordinate information from EuroGCT partners to develop a multilingual website that will give patients, healthcare professionals and the public reliable scientific, legal and ethical information related to cell and gene-based therapies.
It will also provide the research community, regulatory and healthcare authorities with information on the practical steps required for cell and gene therapy development.
The project builds on the success of Edinburgh’s EuroStemCell public engagement project, whose website focusses on engaging the public, patients and educators with stem cell research and regenerative medicine.
Welcome to your home for Gene and Cell Therapy Information | EuroGCT